Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Enterprise Value (2016 - 2026)

Utah Medical Products has reported Enterprise Value over the past 16 years, most recently at -$85.8 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$85.8 million for Q4 2025, down 3.35% from a year ago — trailing twelve months through Dec 2025 was -$85.8 million (down 3.35% YoY), and the annual figure for FY2025 was -$85.8 million, down 3.35%.
  • Enterprise Value for Q4 2025 was -$85.8 million at Utah Medical Products, down from -$84.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for UTMD hit a ceiling of -$56.0 million in Q1 2021 and a floor of -$93.8 million in Q1 2024.
  • Median Enterprise Value over the past 5 years was -$82.6 million (2024), compared with a mean of -$77.7 million.
  • Biggest five-year swings in Enterprise Value: crashed 41.45% in 2021 and later grew 11.17% in 2025.
  • Utah Medical Products' Enterprise Value stood at -$61.0 million in 2021, then fell by 23.09% to -$75.1 million in 2022, then decreased by 23.74% to -$92.9 million in 2023, then rose by 10.65% to -$83.0 million in 2024, then fell by 3.35% to -$85.8 million in 2025.
  • The last three reported values for Enterprise Value were -$85.8 million (Q4 2025), -$84.3 million (Q3 2025), and -$82.2 million (Q2 2025) per Business Quant data.